Core Viewpoint - XOMA Royalty Corporation will participate in the H.C. Wainwright Annual Royalty Company Virtual Conference on May 13, 2025, with key executives featured as speakers [1][2]. Group 1: Conference Participation - CEO Owen Hughes and CIO Brad Sitko will be featured speakers at the conference [1]. - Mr. Hughes will participate in a panel discussion titled "Pros and Cons of Royalty Model – Especially in Current Financing Environment" at 4:00 PM ET [2]. - Mr. Sitko will join the panel "Development-Stage Companies – Where do Royalty and Tech Platforms Play Fit?" at 5:00 PM ET [2]. Group 2: Upcoming Events - Members of XOMA Royalty's business development team will attend the H.C. Wainwright Annual BioConnect Investor Conference on May 20, 2025, in New York, NY [3]. Group 3: Company Overview - XOMA Royalty Corporation is a biotechnology royalty aggregator that helps biotech companies improve human health by acquiring future economic rights associated with therapeutic candidates [4]. - The company provides non-dilutive, non-recourse funding to sellers, allowing them to advance their drug candidates or for general corporate purposes [4]. - XOMA Royalty has a growing portfolio of assets related to the advancement of therapeutic candidates [4].